These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19780861)

  • 1. Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study.
    Skeie L; Bugge H; Negaard A; Bergersen BM
    HIV Med; 2010 Mar; 11(3):170-7. PubMed ID: 19780861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid treatment of facial fat atrophy in HIV-positive patients.
    Bugge H; Negaard A; Skeie L; Bergersen B
    HIV Med; 2007 Nov; 8(8):475-82. PubMed ID: 17944679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density hyaluronic acid for the treatment of HIV-related facial lipoatrophy.
    Pignatti M; Pedone A; Baccarani A; Guaraldi G; Orlando G; Lombardi M; De Santis G
    Aesthetic Plast Surg; 2012 Feb; 36(1):180-5. PubMed ID: 21717261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients.
    Lafaurie M; Dolivo M; Porcher R; Rudant J; Madelaine I; Molina JM
    J Acquir Immune Defic Syndr; 2005 Apr; 38(4):393-8. PubMed ID: 15764955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy.
    Burgess CM; Quiroga RM
    J Am Acad Dermatol; 2005 Feb; 52(2):233-9. PubMed ID: 15692467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.
    Valantin MA; Aubron-Olivier C; Ghosn J; Laglenne E; Pauchard M; Schoen H; Bousquet R; Katz P; Costagliola D; Katlama C
    AIDS; 2003 Nov; 17(17):2471-7. PubMed ID: 14600518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of a Volumizing Hyaluronic Acid Filler for Treatment of HIV-Associated Facial Lipoatrophy.
    Ho D; Jagdeo J
    JAMA Dermatol; 2017 Jan; 153(1):61-65. PubMed ID: 27806168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of one-step rehabilitation of human immunodeficiency virus-related facial lipoatrophy using an injectable calcium hydroxylapatite dermal filler.
    Rauso R; Curinga G; Rusciani A; Colella G; Amore R; Tartaro G
    Dermatol Surg; 2013 Dec; 39(12):1887-94. PubMed ID: 24299576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of polylactic acid implants to correct facial lipoatrophy in human immunodeficiency virus 1-positive individuals receiving combination antiretroviral therapy.
    Cattelan AM; Bauer U; Trevenzoli M; Sasset L; Campostrini S; Facchin C; Pagiaro E; Gerzeli S; Cadrobbi P; Chiarelli A
    Arch Dermatol; 2006 Mar; 142(3):329-34. PubMed ID: 16549708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy].
    Piquet M; Brignol L; Chatelain B; Rey D; Ricbourg B; Meyer C
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):496-504. PubMed ID: 17675198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and color Doppler ultrasound evaluation of polyacrylamide injection in HIV patients with severe facial lipoatrophy secondary to antiretroviral therapy.
    Faundez E; Vega N; Vera E; Vega P; Sepulveda D; Wortsman X
    Skin Res Technol; 2017 May; 23(2):243-248. PubMed ID: 27796065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of hyaluronic acid for soft tissue augmentation of HIV-associated facial lipodystrophy.
    Gooderham M; Solish N
    Dermatol Surg; 2005 Jan; 31(1):104-8. PubMed ID: 15720106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal evaluation of the impact of a polylactic acid injection therapy on health related quality of life amongst HIV patients treated with anti-retroviral agents under real conditions of use.
    Duracinsky M; Leclercq P; Armstrong AR; Dolivo M; Mouly F; Chassany O
    BMC Infect Dis; 2013 Feb; 13():92. PubMed ID: 23425246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) 132 SMILE].
    Lafaurie M; Dolivo M; Girard PM; May T; Bouchaud O; Carbonnel E; Madelaine I; Loze B; Porcher R; Molina JM;
    HIV Med; 2013 Aug; 14(7):410-20. PubMed ID: 23432777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid new formulation: experience in HIV-associated facial lipoatrophy.
    Bechara FG; Gambichler T; Brockmeyer NH; Sand M; Altmeyer P; Hoffmann K
    Dermatology; 2008; 217(3):244-9. PubMed ID: 18663308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary experiences with Bio-Alcamid in HIV facial lipoatrophy.
    Ramon Y; Fodor L; Ullmann Y
    Dermatology; 2007; 214(2):151-4. PubMed ID: 17341865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term efficacy and safety of a subcutaneously injected large-particle stabilized hyaluronic acid-based gel of nonanimal origin in esthetic facial contouring.
    DeLorenzi C; Weinberg M; Solish N; Swift A
    Dermatol Surg; 2009 Feb; 35 Suppl 1():313-21. PubMed ID: 19207320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly-L-lactic acid.
    Perry CM
    Am J Clin Dermatol; 2004; 5(5):361-6; discussion 367-8. PubMed ID: 15554738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients.
    Karim RB; de Lint CA; van Galen SR; van Rozelaar L; Nieuwkerk PT; Askarizadeh E; Hage JJ
    Aesthetic Plast Surg; 2008 Nov; 32(6):873-8. PubMed ID: 18551339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing inflammatory reaction to restylane.
    Soparkar CN; Patrinely JR
    Ophthalmic Plast Reconstr Surg; 2005 Mar; 21(2):151-3. PubMed ID: 15778672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.